Heart Valve Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Prolonged Cardiopulmonary Bypass Time as a Predictive Factor for AGI After Heart Valve Replacement
Condition: Heart Valve Diseases Intervention: Other: CPB time Sponsor: Hepatopancreatobiliary Surgery Institute of Gansu Province Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2022 Category: Research Source Type: clinical trials
PMS Promotes the Recovery of Patients After Heart Valve Replacement
Condition: Heart Valve Diseases Intervention: Dietary Supplement: Probiotic mixture Sponsor: Hepatopancreatobiliary Surgery Institute of Gansu Province Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2022 Category: Research Source Type: clinical trials
Prolonged Cardiopulmonary Bypass Time as a Predictive Factor for AGI After Heart Valve Replacement
Condition: Heart Valve Diseases Intervention: Other: CPB time Sponsor: Hepatopancreatobiliary Surgery Institute of Gansu Province Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2022 Category: Research Source Type: clinical trials
PMS Promotes the Recovery of Patients After Heart Valve Replacement
Condition: Heart Valve Diseases Intervention: Dietary Supplement: Probiotic mixture Sponsor: Hepatopancreatobiliary Surgery Institute of Gansu Province Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2022 Category: Research Source Type: clinical trials
Prolonged Cardiopulmonary Bypass Time as a Predictive Factor for AGI After Heart Valve Replacement
Condition: Heart Valve Diseases Intervention: Other: CPB time Sponsor: Hepatopancreatobiliary Surgery Institute of Gansu Province Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 12, 2022 Category: Research Source Type: clinical trials
Investigation of the ALLEGRA THV System With a New Delivery System in Patients With Aortic Stenosis or Failed Surgical Bioprosthesis
Condition: Transcatheter Aortic Valve Implantation Intervention: Device: (ALLEGRA Transcatheter Heart Valve) TAVI in severe calcified aortic stenosis or in failed surgical aortic bioprosthesis Sponsor: NVT GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2022 Category: Research Source Type: clinical trials